Latest Breaking News On - Hc wainwright global life sciences conference - Page 19 : comparemela.com

DGAP-News: Immunic, Inc. to Participate in Industry and Investor Conferences in March Immunic, Inc. to Participate in Industry and Investor Conferences in March 02.03.2021 / 12:30 Immunic, Inc. to Participate in Industry and Investor Conferences in March NEW YORK, March 2, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced management s participation in the following industry and investor conferences in March: - March 8-9: 2nd Annual European HealthTech CEO Forum. Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, will participate in the Advanced Therapeutics Panel as part of the Pandemic Response Day on Tuesday, March 9, at 1:30 pm CET (7:30 am ET) to discuss the potential of IMU-838 as a treatment option for COVID-19.

Edna kaplanPaula schwartzJessica breuBiocapital europeDaniel vittExchange commissionHc wainwright global life sciences conferenceTherapeutics panelRx communications groupImmunic incDistribution servicesInvestor conferencesAnnual european healthtechChief executive officerGlobal life sciencesAnnual roth